Somatostatin and SMS 201-995 reverse the impairment of cognitive functions induced by cysteamine depletion of brain somatostatin

European Journal of Pharmacology

Volumn 151, Issue 3, 1988, Pages 399-407

  Schettini, Gennaro ^a   Florio, Tullio ^a   Magri, Gianludovico ^a   Grimaldi, Maurizio ^a   Meucci, Olimpia ^a   Landolfi, Elisa ^a   Marino, Adriano ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Adenylate cyclase activity; Avoidance behaviour (active and passive); Cysteamine; Learning and memory; SMS 201 995; Somatostatin

Indexed keywords

ADENYLATE CYCLASE; MERCAPTAMINE; OCTREOTIDE; SOMATOSTATIN;

ANIMAL CELL; ANIMAL EXPERIMENT; AVOIDANCE BEHAVIOR; BRAIN; ENZYME ACTIVITY; FEMALE; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; LEARNING; MEMORY; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

ADENYLATE CYCLASE; ANIMAL; ANTINEOPLASTIC AGENTS; AVOIDANCE LEARNING; BRAIN; COGNITION; CYSTEAMINE; FEMALE; INJECTIONS, INTRAVENTRICULAR; OCTREOTIDE; RATS; RATS, INBRED STRAINS; SOMATOSTATIN; SUPPORT, NON-U.S. GOV'T;

EID: 0023742878     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-2999(88)90536-5     Document Type: Article

References (33)

1. Effects of cysteamine on prosomatostatin related peptides
2. SMS 201-995: A very potent and selective octapeptide analogue of somatostatin with prolonged action
3. A rapid and sensitive method for the quantitation of proteins utilizing the principle of protein dye binding
4. Biological effect of cysteamine: relationship to somatostatin depletion
5. Effects of the novel compound aniracetam (Ro 13-5057) upon impaired learning and memory in rodents
6. Reduced somatostatin-like immunoreactivity in cerebral cortex from cases of Alzheimer disease and Alzheimer senile dementia
7. Somatostatin (SRIF) inhibition of basal and biogenic amines, vasointestinal polypeptide (VIP) and forskolin stimulated adenylate cyclase activity in different brain areas
8. Patients with Alzheimer's disease show an increased content of 15 kdalton somatostatin precursor and lowered levels of tetradecapeptide in their cerebrospinal fluid
9. Neuropeptides in aging and dementia
10. The somatostatin analog SMS 201-995 induces long-acting inhibition of growth hormone secretion without rebound hypersecretion in acromegalic patients
11. Clinical applications of somatostatin analogs
12. Somatostatin immunoreactivity in neuritic plaques of Alzheimer's patients
13. 3H-norepinephrine into the lateral ventricle of the rat brain
14. Selective depletion of somatostatin in rat brain by cysteamine
15. Growth hormone release inhibiting hormone: neuropharmacological studies
16. Location of neuronal tangles in somatostatin neurones in Alzheimer disease
17. Reduced amounts of immunoreactive somatostatin in temporal cortex in senile dementia of Alzheimer type
18. Depletion of somatostatin-like immunoreactivity in the rat central nervous system by cysteamine
19. A highly sensitive adenylate cyclase assay
20. Cysteamine-induced depletion of brain somatostatin (SRIF) disrupts active avoidance conditioning in rats: partial reversal by administration of SRIF analog SMS 201-995; enhancement of SRIF inhibition on brain adenylate cyclase activity
21. Cystaemine-induced depletion of brain somatostatin is associated with up-regulation of cerebrocortical somatostatin receptors
22. Somatostatin in rat tissue is depleted by cystaemine administration
23. Selective decrease of hypothalamic noradrenaline by cystaemine
24. Somatostatin and (d-Trp,d-Cys)-somatostatin delay extinction and reverse electroconvulsive shock induced amnesia in rats
25. The effect of linear somatostatin on the active avoidance behaviour and open-field activity on haloperidol, phenoxybenzamine and atropine pretreated rats
26. Comparative studies with cyclic and linear somatostatin on the active avoidance behaviour and open-field activity in rats
27. Intracerebroventricular somatostatin attenuates electroconvulsive shock-induced amnesia in rats
28. Comparative studies into somatostatin and cystaemine in different behavioural tests on rats
29. Dose related effects of cysteamine treatment on hypothalamic and striatal dopamine, noradrenaline and serotonine neurotransmission
30. The effect of somatostatin on self-stimulation of rats
31. Comparative studies with linear and cyclic somatostatin on self-stimulation of rats
32. The effect of somatostatin on self-stimulation behaviour in atropine- and methysergide-pretreated rats